Aura Biosciences, Inc. (AURA) vs Fulgent Genetics, Inc. (FLGT)
A side-by-side comparison of Aura Biosciences, Inc. and Fulgent Genetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AURA
Aura Biosciences, Inc.
$6.24HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
FLGT
Fulgent Genetics, Inc.
$20.89HealthcareDelayed quote: Oct 6, 2026, 11:34 AM EDT
Total return — AURA vs FLGT
growth of $100 · dividends reinvested · last 5yAURA -58.0% (-15.9%/yr)FLGT -72.9% (-23.0%/yr)AURA compounded faster over this window
AURA FLGT
AURA vs FLGT: by the numbers
- •AURA is the larger company ($646M vs $593M market cap).
- •Both run net losses; AURA's is the smaller (0.00% vs -26.05% net margin).
Metrics side by side
Valuation
| Metric | AURA | FLGT |
|---|---|---|
| P/S ratio | N/A | 1.83 |
| P/B ratio | 2.05 | 0.59 |
Profitability
| Metric | AURA | FLGT |
|---|---|---|
| Gross margin | 0.00% | 35.58% |
| Operating margin | 0.00% | -28.23% |
| Net margin | 0.00% | -26.05% |
| ROE | -41.56% | -8.42% |
| ROIC | -42.02% | -11.80% |
Growth (annualized)
| Metric | AURA | FLGT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -18.66% |
| Total return CAGR (5Y) | N/A | -22.38% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.